The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Conducted internal corporate investigation for a Maryland bank
Conducted internal corporate investigation for a financial institution and negotiated a consent to the issuance of a cease and desist order with the more
License negotiation for an online gaming company
Assisted an online gaming company in connection with their negotiations with a gaming authority with respect to a gaming license. This is an entirely more
Foreign Corrupt Practices Act investigations, compliance and training
Conducted internal investigations for several Fortune 500 companies regarding Foreign Corrupt Practices Act issues in Middle East, Latin more
Copyright infringement litigation defense for one of the world's leading music companies
Represented one of the world's leading music companies in copyright infringement litigation. Summary judgment was granted in favor of our more